| scholarly article | Q13442814 |
| P356 | DOI | 10.1200/JCO.2003.55.135 |
| P953 | full work available at URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2003.55.135 |
| P698 | PubMed publication ID | 14512395 |
| P50 | author | Luigi M Terracciano | Q97082159 |
| P2093 | author name string | Burkhard Micheel | |
| Katharina Glatz-Krieger | |||
| Richard Herrmann | |||
| Christoph Rochlitz | |||
| Peter Jantscheff | |||
| Fritz Grunert | |||
| Urs Metzger | |||
| Jens Brümmer | |||
| Adam Lowy | |||
| Urs Laffer | |||
| P2860 | cites work | The specificity for the differentiation blocking activity of carcinoembryonic antigen resides in its glycophosphatidyl-inositol anchor | Q22254756 |
| Human carcinoembryonic antigen, an intercellular adhesion molecule, blocks fusion and differentiation of rat myoblasts | Q24318694 | ||
| Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas | Q24564315 | ||
| Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas | Q24669773 | ||
| Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation | Q24675101 | ||
| CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor | Q28199550 | ||
| Diversity of gene expression in adenocarcinoma of the lung | Q29616070 | ||
| Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses | Q29616071 | ||
| Tissue microarrays for high-throughput molecular profiling of tumor specimens | Q29618675 | ||
| Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies | Q30724668 | ||
| Homotypic and heterotypic Ca(++)-independent cell adhesion activities of biliary glycoprotein, a member of carcinoembryonic antigen family, expressed on CHO cell surface | Q31049458 | ||
| Four carcinoembryonic antigen subfamily members, CEA, NCA, BGP and CGM2, selectively expressed in the normal human colonic epithelium, are integral components of the fuzzy coat | Q33870113 | ||
| Induction of angiogenesis during the transition from hyperplasia to neoplasia | Q34413571 | ||
| Sequence analysis of carcinoembryonic antigen: identification of glycosylation sites and homology with the immunoglobulin supergene family | Q34595274 | ||
| Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer | Q36115678 | ||
| Carcinoembryonic antigen, a human tumor marker, cooperates with Myc and Bcl-2 in cellular transformation | Q36274013 | ||
| Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients | Q36621223 | ||
| Determination of the specificities of monoclonal antibodies recognizing members of the CEA family using a panel of transfectants | Q36696981 | ||
| Carcinoembryonic antigen gene family: molecular biology and clinical perspectives | Q37469078 | ||
| CEA in tumors of other than colorectal origin | Q37777730 | ||
| Distribution of carcinoembryonic antigen and biologic behavior in colorectal carcinoma | Q38468439 | ||
| The CEACAM1-L glycoprotein associates with the actin cytoskeleton and localizes to cell-cell contact through activation of Rho-like GTPases | Q38477338 | ||
| Carcinoembryonic antigen immunocytochemistry in primary breast cancer | Q39025829 | ||
| A comparative study of the localization of CEA and NCA2 in cancerous and normal gastrointestinal tissues | Q39436747 | ||
| Immunohistochemical localization of carcinoembryonic antigen as a predictor of lymph node status in submucosa-invasive colorectal carcinoma | Q40977819 | ||
| A reappraisal of the value of carcinoembryonic antigen in the management of patients with various neoplasms | Q41440639 | ||
| Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization | Q41666671 | ||
| Identification of membrane antigens in granulocytes and colonic carcinoma cells by a monoclonal antibody specific for biliary glycoprotein, a member of the carcinoembryonic antigen family | Q41696466 | ||
| Expression of carcinoembryonic antigen (CEA) and nonspecific crossreacting antigen (NCA) in gastrointestinal cancer; the correlation with degree of differentiation | Q41815650 | ||
| Oncogenic c-Ki-ras but not oncogenic c-Ha-ras up-regulates CEA expression and disrupts basolateral polarity in colon epithelial cells | Q42446018 | ||
| Expression of CEACAM1 in adenocarcinoma of the lung: a factor of independent prognostic significance | Q44200281 | ||
| Carcinoembryonic antigen as a selective enhancer of colorectal cancer metastasis | Q44567341 | ||
| Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma | Q45952675 | ||
| Redefined nomenclature for members of the carcinoembryonic antigen family | Q48738225 | ||
| Histopathological and prognostic evaluation of immunohistochemical findings in colorectal cancer. | Q50928512 | ||
| Multivariate analysis of a tissue CEA, TPA, and CA 19.9 quantitative study in colorectal cancer patients | Q61900670 | ||
| Tumor-suppressive activity of CD66a in prostate cancer | Q64381391 | ||
| Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule | Q69579655 | ||
| Adjuvant therapy benefits Dukes' C colon cancer patients | Q69755362 | ||
| A colonic tissue architecture assay applied to human colon carcinoma cells | Q73063665 | ||
| Genetic prognostic markers for colorectal cancer | Q73345139 | ||
| Differential expression of CD66a (BGP), a cell adhesion molecule of the carcinoembryonic antigen family, in benign, premalignant, and malignant lesions of the human mammary gland | Q73487975 | ||
| Adjuvant therapy of colon cancer | Q73489460 | ||
| CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease | Q74099040 | ||
| Significance of serum and tissue carcinoembryonic antigen for the prognosis of gastric carcinoma patients | Q74199846 | ||
| Update on adjuvant treatment of colorectal cancer | Q77083121 | ||
| CEACAM1: a marker with a difference or more of the same? | Q78455085 | ||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | oncology | Q162555 |
| colorectal cancer | Q188874 | ||
| colorectal carcinoma | Q25493920 | ||
| neoplastic gene expression regulation | Q66660300 | ||
| P304 | page(s) | 3638-3646 | |
| P577 | publication date | 2003-10-01 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance | |
| Expression of CEACAM6 in Resectable Colorectal Cancer: A Factor of Independent Prognostic Significance | |||
| P478 | volume | 21 |
| Q93111941 | A pretargeted multimodal approach for image-guided resection in a xenograft model of colorectal cancer |
| Q31088597 | Accurate discrimination of pancreatic ductal adenocarcinoma and chronic pancreatitis using multimarker expression data and samples obtained by minimally invasive fine needle aspiration |
| Q39794430 | Anti-metastatic effects of liposomal gemcitabine in a human orthotopic LNCaP prostate cancer xenograft model |
| Q36612082 | Biomarker selection for detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR. |
| Q43852822 | CD66c is a novel marker for colorectal cancer stem cell isolation, and its silencing halts tumor growth in vivo |
| Q38924631 | CEACAM1 and hollow spheroid formation modulate the chemosensitivity of colorectal cancer to 5-fluorouracil |
| Q35794054 | CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease |
| Q35075187 | CEACAM6 as detected by the AP11 antibody is a marker notable for mucin-producing adenocarcinomas |
| Q40572911 | CEACAM6 cross-linking induces caveolin-1-dependent, Src-mediated focal adhesion kinase phosphorylation in BxPC3 pancreatic adenocarcinoma cells |
| Q40251499 | CEACAM6 gene expression in intrahepatic cholangiocarcinoma |
| Q36695688 | CEACAM6 is a determinant of pancreatic adenocarcinoma cellular invasiveness |
| Q81436009 | CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions |
| Q46303343 | CEACAM6 is a prognostic biomarker and potential therapeutic target for gastric carcinoma |
| Q55003874 | CEACAM6 is associated with osteosarcoma metastasis and facilitates epithelial-mesenchymal transition in osteosarcoma cells. |
| Q34514671 | CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway |
| Q37929021 | Carcinoembryonic antigen (CEA) and its receptor hnRNP M are mediators of metastasis and the inflammatory response in the liver |
| Q91666287 | Carcinoembryonic antigen cell adhesion molecule 6 (CEACAM6) in Pancreatic Ductal Adenocarcinoma (PDA): An integrative analysis of a novel therapeutic target |
| Q39051520 | Carcinoembryonic antigen expression level as a predictive factor for response to 5-fluorouracil in colorectal cancer. |
| Q36671897 | Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting. |
| Q38125604 | Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis |
| Q37218048 | Carcinoembryonic cell adhesion molecule 6 in human lung: regulated expression of a multifunctional type II cell protein |
| Q37845669 | Cell surface markers in colorectal cancer prognosis |
| Q64965645 | Co-expression Network Analysis Elucidated a Core Module in Association With Prognosis of Non-functioning Non-invasive Human Pituitary Adenoma. |
| Q33312370 | Colorectal hyperplasia and dysplasia due to human carcinoembryonic antigen (CEA) family member expression in transgenic mice. |
| Q98164461 | Continuous formation of small clusters with LGR5-positive cells contributes to tumor growth in a colorectal cancer xenograft model |
| Q83162381 | Deletion of the carcinoembryonic antigen-related cell adhesion molecule 1 (Ceacam1) gene contributes to colon tumor progression in a murine model of carcinogenesis |
| Q33525547 | Deregulation of the CEACAM expression pattern causes undifferentiated cell growth in human lung adenocarcinoma cells |
| Q37168610 | Design and activity of a murine and humanized anti-CEACAM6 single-chain variable fragment in the treatment of pancreatic cancer. |
| Q35950149 | Distribution and surfactant association of carcinoembryonic cell adhesion molecule 6 in human lung |
| Q41534014 | Dual role of carcinoembryonic antigen-related cell adhesion molecule 6 expression in predicting the overall survival of gastric cancer patients |
| Q34111227 | Dynamic expression of CEACAM7 in precursor lesions of gastric carcinoma and its prognostic value in combination with CEA. |
| Q98386392 | Effect of CEACAM6 silencing on the biological behavior of human gallbladder cancer cells |
| Q41808426 | Effective combination gene therapy using CEACAM6-shRNA and the fusion suicide gene yCDglyTK for pancreatic carcinoma in vitro |
| Q38946429 | Emerging Role and Targeting of Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) in Human Malignancies |
| Q39067515 | Expression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in breast cancers. |
| Q54369091 | Expression and prognostic significance of CEACAM6, ITGB1, and CYR61 in peripheral blood of patients with gastric cancer. |
| Q36597875 | Expression of human carcinoembryonic antigen-related cell adhesion molecule 6 and alveolar progenitor cells in normal and injured lungs of transgenic mice |
| Q33268089 | Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers |
| Q36954024 | FOXP3 and CEACAM6 expression and T cell infiltration in the occurrence and development of colon cancer |
| Q92846263 | Gene Expression Changes Accompanying the Duodenal Adenoma-Carcinoma Sequence in Familial Adenomatous Polyposis |
| Q36611515 | High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer |
| Q35322339 | Hollow spheroids beyond the invasive margin indicate the malignant potential of colorectal cancer |
| Q36140775 | ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer |
| Q34913566 | Identification of genes differentially expressed in benign versus malignant thyroid tumors |
| Q36502358 | Identification of metastasis-associated genes in colorectal cancer using metaDE and survival analysis |
| Q39905696 | Interdependency of CEACAM-1, -3, -6, and -8 induced human neutrophil adhesion to endothelial cells |
| Q35870320 | Interleukin-6 trans-signaling increases the expression of carcinoembryonic antigen-related cell adhesion molecules 5 and 6 in colorectal cancer cells |
| Q34097582 | Investigations on the usefulness of CEACAMs as potential imaging targets for molecular imaging purposes |
| Q64234835 | Levels of CEACAM6 in Peripheral Blood Are Elevated in Patients with Plasma Cell Disorders: A Potential New Diagnostic Marker and a New Therapeutic Target? |
| Q28116258 | MicroRNA-29a suppresses the growth, migration, and invasion of lung adenocarcinoma cells by targeting carcinoembryonic antigen-related cell adhesion molecule 6 |
| Q35119983 | MicroRNA-dependent regulation of transcription in non-small cell lung cancer |
| Q55094334 | Microbial markers in colorectal cancer detection and/or prognosis. |
| Q24803325 | Myeloid antigens in childhood lymphoblastic leukemia: clinical data point to regulation of CD66c distinct from other myeloid antigens |
| Q33323250 | Overexpression of CEACAM6 in borderline and invasive mucinous ovarian neoplasms |
| Q36750956 | P4H9-detected molecule expression on spindle-shaped fibroblasts indicates malignant phenotype of colorectal cancer |
| Q34432882 | Preoperative low dose NSAID treatment influences the genes for stemness, growth, invasion and metastasis in colorectal cancer. |
| Q47733488 | Prognostic value of carcinoembryonic antigen distribution in tumor tissue of colorectal carcinoma. |
| Q35413473 | Protein glycosylation in cancer |
| Q36836615 | RNAi-mediated knockdown of target genes: a promising strategy for pancreatic cancer research |
| Q39574908 | Re-expression of CEACAM1 long cytoplasmic domain isoform is associated with invasion and migration of colorectal cancer |
| Q35840406 | Recent advances in the tumour biology of the GPI-anchored carcinoembryonic antigen family members CEACAM5 and CEACAM6. |
| Q37327479 | Systematic large-scale meta-analysis identifies a panel of two mRNAs as blood biomarkers for colorectal cancer detection |
| Q54700470 | Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer. |
| Q33685236 | T cell immunity induced by a bivalent Salmonella-based CEACAM6 and 4-1BBL vaccines in a rat colorectal cancer model |
| Q35956062 | The Role of Biliary Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 6 (CEACAM6) as a Biomarker in Cholangiocarcinoma |
| Q33735551 | The Roles of Carcinoembryonic Antigen in Liver Metastasis and Therapeutic Approaches |
| Q93046345 | Therapeutic Effect of pHLIP-mediated CEACAM6 Gene Silencing in Lung Adenocarcinoma |
| Q47432914 | Towards understanding the mechanisms of actions of carcinoembryonic antigen-related cell adhesion molecule 6 in cancer progression. |
Search more.